HER3 expression and MEK activation in non-small-cell lung carcinoma.

Thubeena ManickavasagarWei YuanSuzanne CarreiraBora GurelSusana MirandaAna FerreiraMateus CrespoRuth RiisnaesChloe BakerMary O'BrienJaishree BhosleSanjay PopatUdai BanerjiJuanita LopezJohann de BonoAnna R Minchom

Published in: Lung cancer management (2021)

HER3 expression is common and is a potential therapeutic target by virtue of frequent overexpression and functional downstream signaling.

Keyphrases

poor prognosis
single cell
binding protein
cell proliferation
stem cells
transcription factor
pi k akt
human health
climate change